The October 17 issue of Science Translational Medicine features the latest results of Institute for Therapeutics Discovery & Development faculty in the article "A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer." ITDD directors Gunda Georg and Vadim Gurvich are working with other University of Minnesota researchers to develop Minnelide, a new drug to treat pancreatic cancer.
Drs. Gunda Georg & Vadim Gurvich - Minnelide research
TrackBack URL: http://blog.lib.umn.edu/cgi-bin/mt-tb.cgi/198109